Characteristic | Report of pica (n = 118)2 | No report of pica (n = 144) | Value of p3 |
---|---|---|---|
Age, y | 50 ± 15 | 55 ± 17 | 0.0041 |
Women, % (n) | 91.5 (108) | 84.7 (122) | 0.0943 |
White, % (n) | 75.4 (89) | 87.5 (126) | 0.0113 |
Body mass index, kg/m2 | 29.7 ± 8.1 | 29.3 ± 7.7 | 0.6667 |
Fatigue, % (n) | 46.6 (55) | 41.7 (60) | 0.4224 |
Cardiopulmonary symptoms, % (n) | 43.2 (51) | 29.2 (42) | 0.0180 |
Epithelial manifestations, % (n) | 29.7 (35) | 18.8 (7) | 0.0387 |
Mental symptoms, % (n) | 5.9 (7) | 4.2 (6) | 0.5126 |
Neuromuscular symptoms, % (n) | 5.9 (7) | 4.9 (7) | 0.7013 |
Gastrointestinal blood loss, % (n) | 36.4 (43) | 47.2 (68) | 0.2411 |
Reproductive blood loss, % (n) | 40.7 (48) | 25.0 (36) | 0.0068 |
Epistaxis, % (n) | 0 | 1.4 (2) | 0.3011 |
Hematuria, % (n) | 0.8 (1) | 1.4 (2) | 0.5745 |
Medical blood loss, % (n) | 7.6 (9) | 15.3 (22) | 0.0564 |
Chronic malabsorption, % (n) | 12.7 (15) | 9.7 (14) | 0.4429 |
Unknown cause of iron deficiency/depletion, % (n) | 8.5 (10) | 6.3 (9) | 0.4897 |
Hemoglobin, g/L | 100 ± 22 | 107 ± 22 | 0.0251 |
MCV, fL | 75.0 ± 13.0 | 80.8 ± 9.0 | 0.0001 |
RBC × 1012/L | 4.15 ± 0.64 | 4.08 ± 0.70 | 0.4232 |
RDW, % | 18.6 ± 3.7 | 17.2 ± 2.7 | 0.0006 |
Platelets × 109/L | 352 ± 146 | 305 ± 113 | 0.0046 |
Lymphocytes × 109/L | 1.9 ± 0.7 | 2.0 ± 1.0 | 0.4120 |
Neutrophils × 109/L | 4.3 ± 2.1 | 4.3 ± 2.1 | 0.9327 |
SI, μmol/L | 7 ± 5 | 8 ± 5 | 0.1304 |
TIBC, μmol/L | 75 ± 13 | 72 ± 14 | 0.0476 |
TS, % | 10 ± 7 | 11 ± 7 | 0.1124 |
SF, pmol/L | 27 ± 22 | 34 ± 25 | 0.0248 |
Cancer in remission, % | 7.6 (9) | 18.1 (26) | 0.0136 |
CVID, % | 11.0 (13) | 18.1 (26) | 0.1113 |
Diabetes mellitus, % | 11.9 (14) | 18.1 (26) | 0.1657 |
Hemochromatosis, % | 0.8 (1) | 2.8 (4) | 0.2533 |
Anemia, % (n) | 79.7 (94) | 69.4 (100) | 0.0605 |
Thrombocytosis, % (n) | 20.4 (24) | 8.3 (12) | 0.0050 |
Thrombocytopenia, % (n) | 3.4 (4) | 4.2 (6) | 0.5031 |
Iron deficiency, % (n) | 55.6 (80) | 69.5 (82) | 0.0720 |
Iron deficiency with anemia, % (n) | 43.8 (63) | 54.2 (62) | 0.1495 |